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Case Summary. An 18-year old man presented with a three-week history of abdominal pain, weight loss and bloody diarrhoea. He
was profoundly septic, with generalised abdominal tenderness. CT and ﬂexible sigmoidosopy conﬁrmed colitis of the colon with
rectal sparing. Laparotomy was performed when conservative management failed to improve his condition. Subtotal colectomy,
with end ileostomyand mucus ﬁstula formation,was performed in light of active colitis. Despite successful operative intervention
the patient acute left ventricular failure, raising the possibility of giant cell myocarditis, which fully resolved before a deﬁnitive
diagnosis could be reached. Discussion. It is possible that the transient cardiac failure in this case may represent an overwhelming
inﬂammatory response or myocarditis. Inﬂammatory bowel disease is rarely associated with giant cell myocarditis (GCM). GCM
usually aﬀects a young population and its prognosis is variable, ranging from complete recovery, remission with recurrence and
fatality. The management of this group of patients is still relatively experimental. Conclusion. Fulminant colitis can be associated
with a rapid deterioration in cardiac function. Causes include sepsis, systemic inﬂammatory response syndrome or myocarditis.
GCM should be considered in patients with new onset of left ventricular failure that decline rapidly.
1.CaseReport
A previously well 18-year-old carpet ﬁtter presented with a
three-week history of progressive abdominal pain, anorexia,
and 10Kg weight loss. There was associated diarrhoea, with
blood and mucus mixed with stool, nausea, and vomiting.
He denied any pyrexia or rigors, foreign travel, or ingesting
any unusual food. There was no signiﬁcant medical history
or family history. On examination the patient was severely
dehydrated, cahexic, hypotensive, and tachycardic. Cardio-
vascular examination was otherwise unremarkable and a
soft, nonperitonitic abdomen with generalised tenderness
was detected. The abdomen was not distended and no
organomegaly was identiﬁed. Rectal examination detected
no abnormality, except for a small perianal ﬁstula. A
diagnosis of severe dehydration secondary to either colitis or
gastroenteritis was made, and aggressive ﬂuid resuscitation
commenced.
The patient’s condition deteriorated after aggressive ﬂuid
resuscitation (ﬁve litres of crystalloid ﬂuid over 2 hours).
He remained in shock (pulse 160bpm, blood pressure
86/50mmHg) and became tachypnoeic (respiratory rate
50) and hypoxic (saturations 83% on air). Repeat exam-
ination revealed an elevated jugular venous pulse (6cm)
and widespread wheeze throughout both lung ﬁelds. Some
diﬀuse lower abdominal tenderness was again seen, but
no evidence of distension or peritonism. Haematological
investigations revealed an elevated CRP, but normal white
cell count and lactate. Arterial blood gas conﬁrmed hypoxia
in addition to compensated metabolic acidosis. Pulmonary
oedema was seen on a chest radiograph, and an echocardio-
gram showed right bundle branch block.
It was thought that the patient might have colitis with
systemic inﬂammatory response syndrome causing acute
pulmonaryoedema.Thepatient’srespiratory signsimproved
with frusemide and associated diuresis, but his tachycardia
and hypotension persisted. Ionotropic support and nonin-
vasive oxygen therapy commenced, although his respiratory
eﬀort declined and he was subsequently ventilated. After
a period of stabilisation an ultrasound was performed,
which noted some thickening of the caecal wall, which was
conﬁrmed with abdominal computed tomography (CT),
which also identiﬁed distended loops of both large and small2 ISRN Surgery
Figure1:AbdominalCTshowingmultipleoedematousanddilated
loops of both small and large bowel.
bowel (Figure 1). A ﬂexible sigmoidoscopy conﬁrmed an
oedematous mucosa (consistent with inﬂammatory bowel
disease), with rectal sparing. Multiple biopsies were taken.
Conservative and interventional management options
w e r ec o n s i d e r e d .I tw a st h o u g h tt h a tt h em e d i c a lm a n a g e -
mentofthe colitiswould notprovesuccessful giventherapid
decline in the patient’s condition. Operative intervention
to remove the aﬀected bowel was thought to be the most
beneﬁcial option. At laparotomy active colonic colitis was
conﬁrmed and copious clear peritoneal ﬂuid seen, although
there was no perforation. A subtotal colectomy with end
ileostomy and mucus ﬁstula formation was performed. It
was thought that this was an acute inﬂammatory process
and probably due to ulcerative colitis, with a possibility
of superimposed infection. Histological examination of
the resected specimen identiﬁed fulminant colitis with a
cobblestonemucosaand inﬂammation involving the mucosa
and submucosa. In addition, pseudopolyps, cryptitis, and
cryptabscesseswerenoted,butnogranulomataorfeaturesof
pseudomembranous colitis seen. Subsequent viral serologies
(including inﬂuenza, adenovirus, lyme disease, and yersinia)
were all negative.
Postoperatively the patient continued to require
ionotropic support. A transthoracic echocardiography
showed left ventricular failure, with an ejection fraction of
20%. Cardiology review hypothesised that the poor cardiac
function could be due to inﬂammatory disease causing giant
cell myocarditis, and it was thought that this had a very
high mortality. Management options were again reassessed,
with cardiac biopsy and a heart-lung transplant considered.
However, the patient’s condition improved with supportive
management. His cardiac failure resolved, and repeat
echocardiography at 11 days showed that left ventricular
function had returned to normal. After full recovery he was
discharged, and he awaits further cardiology review.
2.Discussion
Myocarditis (cardiac muscle inﬂammation) is associated
with symptoms of congestive cardiac failure, chest pain,
arrhythmias, syncope, and sudden death [1–3]. Myocarditis
can be broadly classiﬁed into infective and noninfective
causes. Infective causes include viral (both DNA and RNA),
bacterial, mycobacterial, fungal, protozoal, rickettsi, chlamy-
diae, and parasitic [2]. Noninfective mechanisms include
environmental factors (toxins, alcohol, and chemotherapy),
metabolic abnormalities or, more frequently, immunological
factors [2].
Inﬂammatory bowel disease is uncommonly associated
with cardiac disease [1–3]. These extraintestinal manifes-
tations include pericarditis, pericardial eﬀusion, myocardi-
tis, myocardial infarction, endocarditis, and arrhythmias
[1, 3]. Although rare, myocardial inﬂammation related to
inﬂammatory bowel disease is normally associated with the
presence of multinucleate giant cells [1–3].
The presence of inﬂammatory bowel disease and cardiac
dysfunction in this patient is therefore highly suggestive
of GCM, although a cardiac biopsy was not performed to
conﬁrm diagnosis. GCM is a poorly understood disease,
and it can be idiopathic in origin or associated with
autoimmune disorders and inﬂammatory bowel disease
[1, 3, 4]. GCM usually aﬀects a young population and
its prognosis is variable, ranging from complete recovery,
remission with recurrence, and fatality [1,3,4].The majority
of patients have a rapid fatal decline after presentation
[1, 3–5]. The management of this group of patients is still
relatively experimental. Triple immunosuppression therapy
and cardiac transplantation has been recommended [4, 5].
However, there have been cases of recurrence of GCM in
cardiac transplants [4].
3.Conclusion
This case highlights how fulminant colitis can be associated
with a rapid deterioration in cardiac function. The cause
of this patient’s transient phenomena is unclear and could
either be due to an overwhelming systemic inﬂammatory
response syndrome or to a myocarditis. Resection of the
aﬀected segment of bowel proved an eﬀective treatment,
resulting in the restoration of cardiac function. Giant-cell
myocarditis (GCM) should be considered in patients with
new onset of left ventricular failure that decline rapidly [1].
References
[1] L. T. Cooper, G. J. Berry, and R. Shabetai, “Idiopathic giant-cell
myocarditis—naturalhistoryand treatment,” The New England
Journal of Medicine, vol. 336, no. 26, pp. 1860–1866, 1997.
[2] F. Calabrese and G. Thiene, “Myocarditis and inﬂammatory
cardiomyopathy: microbiological and molecular biological
aspects,” Cardiovascular Research, vol. 60, no. 1, pp. 11–25,
2003.
[ 3 ]C .L .N a s h ,R .P a n a c c i o n e ,L .R .S u t h e r l a n d ,a n dJ .B .
Meddings, “Giant cell myocarditis, in a patient with Crohn’s
disease, treated with etanercept—a tumour necrosis factor-
alphaantagonist,”Canadian JournalofGastroenterology,vol.15,
no. 9, pp. 607–611, 2001.
[ 4 ]A .A r i z a ,M .D .L ´ opez, J. L. Mate, A. Cur´ os, M. Villagrasa,
and J. J. Navas-Palacios, “Giant cell myocarditis: monocytic
immunophenotype of giant cells in a case associated withISRN Surgery 3
ulcerative colitis,”Human Pathology,vol.26,no.1,pp.121–123,
1995.
[ 5 ]L .T .C o o p e r ,G .J .B e r r y ,M .R i z e q ,a n dJ .S .S c h r o e d e r ,“ G i a n t
cell myocarditis,” Journal of Heart and Lung Transplantation,
vol. 14, no. 2, pp. 394–401, 1995.